Literature DB >> 3462697

Reaction of nucleic acids and cis-diamminedichloroplatinum(II) in the presence of intercalating agents.

J M Malinge, M Leng.   

Abstract

The reaction of cis-diamminedichloroplatinum(II) and several synthetic or natural double-stranded polydeoxyribonucleotides has been carried out in the presence of such intercalating agents as ethidium bromide, proflavine, and acridine. After incubation of the reaction mixtures at 37 degrees C for 24 hr, some ethidium or proflavine, but no acridine, molecules are tightly bound to nucleic acids. Tight binding is defined by resistance to extraction with butanol, assayed by filtration at acid pH or by thin-layer chromatography at basic pH. In the ternary complexes, there is about one tightly bound ethidium (or proflavine) per platinum residue. At 37 degrees C, but not at 4 degrees C, tightly bound ethidium exchanges with free ethidium, whereas platinum residues do not exchange. The binding and the release of tightly bound ethidium are very slow (several hours). It is suggested that in the ternary complexes, nucleic acid-cis-Pt(NH3)2-intercalating agent, a bidentate adduct (guanine-ethidium or -proflavine)-cis-Pt(NH3)2, is formed. No tightly bound ethidium or proflavine is found when cis-diamminedichloroplatinum(II) is replaced by trans-diamminedichloroplatinum(II). Competition experiments between cis-diamminedichloroplatinum(II), poly(dG-dC), and poly(dG)-poly(dC) or poly(dA-dT) show that the presence of ethidium bromide, proflavine, or acridine interferes with the distribution of platinum between the polynucleotides. These results might help to explain the synergism for drugs used in combination with cis-diamminedichloroplatinum(II) and in the design of new chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3462697      PMCID: PMC386494          DOI: 10.1073/pnas.83.17.6317

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

Review 1.  Left-handed Z-DNA.

Authors:  M Leng
Journal:  Biochim Biophys Acta       Date:  1985-08-21

2.  Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II).

Authors:  A Eastman
Journal:  Biochemistry       Date:  1983-08-02       Impact factor: 3.162

Review 3.  The chemistry and biology of left-handed Z-DNA.

Authors:  A Rich; A Nordheim; A H Wang
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

4.  Ethidium bromide alters the binding mode of cis-diamminedichloroplatinum(II) to pBR322 DNA.

Authors:  C M Merkel; S J Lippard
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1983

5.  Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II).

Authors:  A L Pinto; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  Ethidium bromide changes the nuclease-sensitive DNA binding sites of the antitumor drug cis-diamminedichloroplatinum(II).

Authors:  T D Tullius; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

7.  Immunological and spectroscopic studies of poly(dG-dC).poly(dG-dC) modified by cis-diamminedichloroplatinum(II).

Authors:  J M Malinge; M Ptak; M Leng
Journal:  Nucleic Acids Res       Date:  1984-07-25       Impact factor: 16.971

8.  Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.

Authors:  A M Fichtinger-Schepman; J L van der Veer; J H den Hartog; P H Lohman; J Reedijk
Journal:  Biochemistry       Date:  1985-01-29       Impact factor: 3.162

9.  New chemistry of an old molecule: cis-[Pt(NH3)2Cl2].

Authors:  S J Lippard
Journal:  Science       Date:  1982-12-10       Impact factor: 47.728

10.  Reaction of cis-diamminedichloroplatinum (II) and DNA in B or Z conformation.

Authors:  J M Malinge; M Leng
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

View more
  8 in total

1.  Reactivity of monofunctional cis-platinum adducts as a function of DNA sequence.

Authors:  J M Malinge; M Leng
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

2.  Possible catalytic activity of DNA in the reaction between the antitumor drug cis-diamminedichloroplatinum(II) and the intercalator N-methyl-2,7-diazapyrenium.

Authors:  F Gaucheron; J M Malinge; A J Blacker; J M Lehn; M Leng
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.

Authors:  D Payet; F Gaucheron; M Sip; M Leng
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

4.  Lability of monofunctional cis-platinum adducts: role of DNA double helix.

Authors:  M F Anin; F Gaucheron; M Leng
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

5.  Interaction of novel bis(platinum) complexes with DNA.

Authors:  J D Roberts; B Van Houten; Y Qu; N P Farrell
Journal:  Nucleic Acids Res       Date:  1989-12-11       Impact factor: 16.971

6.  Monofunctional and higher-valent platinum anticancer agents.

Authors:  Timothy C Johnstone; Justin J Wilson; Stephen J Lippard
Journal:  Inorg Chem       Date:  2013-06-05       Impact factor: 5.165

7.  Characterization of the ternary complexes formed in the reaction of cis-diamminedichloroplatinum (II), ethidium bromide and nucleic acids.

Authors:  J M Malinge; A Schwartz; M Leng
Journal:  Nucleic Acids Res       Date:  1987-02-25       Impact factor: 16.971

8.  Formation of a DNA monofunctional cis-platinum adduct cross-linking the intercalating drug N-methyl-2,7-diazapyrenium.

Authors:  J M Malinge; M Sip; A J Blacker; J M Lehn; M Leng
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.